LMR GEORGETTE PMHNP BOARD EXAM REVIEW PSYCHIATRIC
2026/2027 - QUESTIONS AND ANSWERS 100% VERIFIED
DETAILED RATIONALES - PASS GUARANTEED - A+ GRADED
145 Questions with Answers and Detailed Rationales
100 PERCENT GUARANTEED PASS
INSTANT DOWNLOAD ANSWERS INCLUDED
IMPORTANCE OF THIS DOCUMENT
This comprehensive examination preparation guide has been meticulously developed to help you succeed in the
LMR GEORGETTE PMHNP BOARD EXAM REVIEW PSYCHIATRIC 2026/2027 - QUESTIONS AND ANSWERS
100% VERIFIED DETAILED RATIONALES - PASS GUARANTEED - A+ GRADED. It contains 145 carefully
selected questions that reflect the most current exam content and testing strategies. Each question is
accompanied by a correct answer and a detailed rationale that explains the underlying pathophysiology,
pharmacology, or clinical reasoning.
Self-Assessment – Test your knowledge and Exam Preparation – Familiarize yourself with the
identify areas requiring further question format and content
study areas
Concept Reinforcement – Deepen your Confidence Building – Develop test-taking
understanding through strategies and reduce
evidence-based exam anxiety
rationales
Time Management – Practice answering
questions under simulated
exam conditions
Review Summary 145 Questions
Foundations - Application - LMR Georgette Pmhnp Board Review Psychiatric 2026/2027 AND 100 Detailed
Rationales PASS Guaranteed A Psychiatric-mental Health Nurse Practitioner Pmhnp Board Review Graduate
Pmhnp Board Certification Review
All answers with rationales
,Table of Contents
Content Area Questions Key Topics
LMR Georgette Pmhnp Board 1-25 Disorder, Lithium, Mechanism, Clozapine, Develops
Review Psychiatric 2026/2027
AND 100 Detailed Rationales
PASS Guaranteed A
Psychiatric-mental Health
Nurse Practitioner Pmhnp
Board Review Graduate
Pmhnp Board Certification
Review
Lithium 26-50 Disorder, Develops, Clozapine, Finding, Schizophrenia
Finding 51-75 Disorder, Mechanism, Lithium, Syndrome, Intervention
Mechanism 76-100 Disorder, Lithium, Schizophrenia, Appropriate,
Treatment-resistant
Develops 101-125 Disorder, Appropriate, Lithium, Finding, Self-harm
Schizophrenia 126-145 Reflects, Finding, Develops, Explains, Current
TOTAL 145 All questions include answers and detailed rationales
,Section A - LMR Georgette Pmhnp Board Review
Psychiatric 2026/2027 AND 100 Detailed Rationales PASS
Guaranteed A Psychiatric-mental Health Nurse Practitioner
Pmhnp Board Review Graduate Pmhnp Board Certification
Review
Q1.
A patient on long-term lithium therapy presents with coarse tremor, ataxia, and confusion.
Serum lithium level is 2.1 mEq/L, creatinine has risen 40% from baseline, and TSH is
elevated. Which intervention sequence is most appropriate?
A. Hold lithium, administer IV fluids, and B. Hold lithium, give levothyroxine for
prepare for hemodialysis if levels do not fall hypothyroidism, and recheck level in 24
below 1.5 mEq/L within 6 hours. hours.
C. Continue lithium at reduced dose, add D. Administer activated charcoal, force
propranolol for tremor, and monitor diuresis with furosemide, and recheck level
outpatient. in 12 hours.
Correct: A - Hold lithium, administer IV fluids, and prepare for hemodialysis if levels do
not fall below 1.5 mEq/L within 6 hours.
Rationale:Lithium toxicity with renal impairment and neurologic symptoms requires
immediate discontinuation, IV hydration, and hemodialysis if levels remain >1.5 mEq/L or
symptoms persist. Levothyroxine treats hypothyroidism but not acute toxicity; propranolol
masks tremor without addressing toxicity; activated charcoal does not bind lithium and
furosemide can worsen renal function.
Q2.
Which neurobiological mechanism best explains the delayed therapeutic effect of SSRIs in
major depressive disorder?
A. Downregulation of presynaptic 5-HT1A B. Immediate blockade of serotonin
autoreceptors leading to increased reuptake transporters increasing synaptic
serotonergic neurotransmission serotonin within hours
C. Upregulation of postsynaptic 5-HT2A D. Direct inhibition of monoamine oxidase
receptors enhancing cortical excitability increasing norepinephrine availability
Correct: A - Downregulation of presynaptic 5-HT1A autoreceptors leading to increased
serotonergic neurotransmission
Page 3
, Section A - LMR Georgette Pmhnp Board Review Psychiatric 2026/2027 AND 100 Detailed Rationales PASS Guaranteed A Psychiatric-mental
Health Nurse Practitioner Pmhnp Board Review Graduate Pmhnp Board Certification Review
Rationale: SSRIs initially increase synaptic serotonin, but therapeutic effects lag due to
gradual desensitization of 5-HT1A autoreceptors, enhancing serotonergic transmission.
Immediate transporter blockade (B) occurs but does not explain delay. 5-HT2A upregulation
(C) is not the mechanism. MAO inhibition (D) describes a different drug class.
Q3.
A patient with schizophrenia on clozapine develops fever, tachycardia, and a WBC of
2,500/mm³ with absolute neutrophil count of 1,200/mm³. Which action is priority?
A. Discontinue clozapine immediately and B. Reduce clozapine dose by 50% and add
obtain daily CBC with differential until ANC filgrastim
>1,500/mm³
C. Continue clozapine and monitor weekly D. Switch to olanzapine and recheck CBC in
CBC 2 weeks
Correct: A - Discontinue clozapine immediately and obtain daily CBC with differential until
ANC >1,500/mm³
Rationale:Clozapine-induced neutropenia (ANC <1,500/mm³) requires immediate
discontinuation and daily CBC monitoring until recovery. Dose reduction or continuation risks
agranulocytosis. Switching to olanzapine does not address acute neutropenia and delays
monitoring.
Q4.
Which statement accurately reflects the 2024 FDA guidance on esketamine for
treatment-resistant depression?
A. It is approved for at-home B. It requires a 2-hour post-dose
self-administration after initial tolerance. observation period in a certified healthcare
setting.
C. It is contraindicated in patients with a D. It is approved only for bipolar depression,
history of substance use disorder. not unipolar depression.
Correct: B - It requires a 2-hour post-dose observation period in a certified healthcare
setting.
Rationale:Esketamine must be administered in a certified setting with 2-hour monitoring for
dissociation and blood pressure changes. At-home use is not approved. Substance use
disorder is a caution, not absolute contraindication. It is approved for treatment-resistant
unipolar depression, not bipolar depression.
Q5.
A patient with borderline personality disorder engages in self-harm when feeling
abandoned. Which psychotherapy approach has the strongest evidence for reducing
Page 4
2026/2027 - QUESTIONS AND ANSWERS 100% VERIFIED
DETAILED RATIONALES - PASS GUARANTEED - A+ GRADED
145 Questions with Answers and Detailed Rationales
100 PERCENT GUARANTEED PASS
INSTANT DOWNLOAD ANSWERS INCLUDED
IMPORTANCE OF THIS DOCUMENT
This comprehensive examination preparation guide has been meticulously developed to help you succeed in the
LMR GEORGETTE PMHNP BOARD EXAM REVIEW PSYCHIATRIC 2026/2027 - QUESTIONS AND ANSWERS
100% VERIFIED DETAILED RATIONALES - PASS GUARANTEED - A+ GRADED. It contains 145 carefully
selected questions that reflect the most current exam content and testing strategies. Each question is
accompanied by a correct answer and a detailed rationale that explains the underlying pathophysiology,
pharmacology, or clinical reasoning.
Self-Assessment – Test your knowledge and Exam Preparation – Familiarize yourself with the
identify areas requiring further question format and content
study areas
Concept Reinforcement – Deepen your Confidence Building – Develop test-taking
understanding through strategies and reduce
evidence-based exam anxiety
rationales
Time Management – Practice answering
questions under simulated
exam conditions
Review Summary 145 Questions
Foundations - Application - LMR Georgette Pmhnp Board Review Psychiatric 2026/2027 AND 100 Detailed
Rationales PASS Guaranteed A Psychiatric-mental Health Nurse Practitioner Pmhnp Board Review Graduate
Pmhnp Board Certification Review
All answers with rationales
,Table of Contents
Content Area Questions Key Topics
LMR Georgette Pmhnp Board 1-25 Disorder, Lithium, Mechanism, Clozapine, Develops
Review Psychiatric 2026/2027
AND 100 Detailed Rationales
PASS Guaranteed A
Psychiatric-mental Health
Nurse Practitioner Pmhnp
Board Review Graduate
Pmhnp Board Certification
Review
Lithium 26-50 Disorder, Develops, Clozapine, Finding, Schizophrenia
Finding 51-75 Disorder, Mechanism, Lithium, Syndrome, Intervention
Mechanism 76-100 Disorder, Lithium, Schizophrenia, Appropriate,
Treatment-resistant
Develops 101-125 Disorder, Appropriate, Lithium, Finding, Self-harm
Schizophrenia 126-145 Reflects, Finding, Develops, Explains, Current
TOTAL 145 All questions include answers and detailed rationales
,Section A - LMR Georgette Pmhnp Board Review
Psychiatric 2026/2027 AND 100 Detailed Rationales PASS
Guaranteed A Psychiatric-mental Health Nurse Practitioner
Pmhnp Board Review Graduate Pmhnp Board Certification
Review
Q1.
A patient on long-term lithium therapy presents with coarse tremor, ataxia, and confusion.
Serum lithium level is 2.1 mEq/L, creatinine has risen 40% from baseline, and TSH is
elevated. Which intervention sequence is most appropriate?
A. Hold lithium, administer IV fluids, and B. Hold lithium, give levothyroxine for
prepare for hemodialysis if levels do not fall hypothyroidism, and recheck level in 24
below 1.5 mEq/L within 6 hours. hours.
C. Continue lithium at reduced dose, add D. Administer activated charcoal, force
propranolol for tremor, and monitor diuresis with furosemide, and recheck level
outpatient. in 12 hours.
Correct: A - Hold lithium, administer IV fluids, and prepare for hemodialysis if levels do
not fall below 1.5 mEq/L within 6 hours.
Rationale:Lithium toxicity with renal impairment and neurologic symptoms requires
immediate discontinuation, IV hydration, and hemodialysis if levels remain >1.5 mEq/L or
symptoms persist. Levothyroxine treats hypothyroidism but not acute toxicity; propranolol
masks tremor without addressing toxicity; activated charcoal does not bind lithium and
furosemide can worsen renal function.
Q2.
Which neurobiological mechanism best explains the delayed therapeutic effect of SSRIs in
major depressive disorder?
A. Downregulation of presynaptic 5-HT1A B. Immediate blockade of serotonin
autoreceptors leading to increased reuptake transporters increasing synaptic
serotonergic neurotransmission serotonin within hours
C. Upregulation of postsynaptic 5-HT2A D. Direct inhibition of monoamine oxidase
receptors enhancing cortical excitability increasing norepinephrine availability
Correct: A - Downregulation of presynaptic 5-HT1A autoreceptors leading to increased
serotonergic neurotransmission
Page 3
, Section A - LMR Georgette Pmhnp Board Review Psychiatric 2026/2027 AND 100 Detailed Rationales PASS Guaranteed A Psychiatric-mental
Health Nurse Practitioner Pmhnp Board Review Graduate Pmhnp Board Certification Review
Rationale: SSRIs initially increase synaptic serotonin, but therapeutic effects lag due to
gradual desensitization of 5-HT1A autoreceptors, enhancing serotonergic transmission.
Immediate transporter blockade (B) occurs but does not explain delay. 5-HT2A upregulation
(C) is not the mechanism. MAO inhibition (D) describes a different drug class.
Q3.
A patient with schizophrenia on clozapine develops fever, tachycardia, and a WBC of
2,500/mm³ with absolute neutrophil count of 1,200/mm³. Which action is priority?
A. Discontinue clozapine immediately and B. Reduce clozapine dose by 50% and add
obtain daily CBC with differential until ANC filgrastim
>1,500/mm³
C. Continue clozapine and monitor weekly D. Switch to olanzapine and recheck CBC in
CBC 2 weeks
Correct: A - Discontinue clozapine immediately and obtain daily CBC with differential until
ANC >1,500/mm³
Rationale:Clozapine-induced neutropenia (ANC <1,500/mm³) requires immediate
discontinuation and daily CBC monitoring until recovery. Dose reduction or continuation risks
agranulocytosis. Switching to olanzapine does not address acute neutropenia and delays
monitoring.
Q4.
Which statement accurately reflects the 2024 FDA guidance on esketamine for
treatment-resistant depression?
A. It is approved for at-home B. It requires a 2-hour post-dose
self-administration after initial tolerance. observation period in a certified healthcare
setting.
C. It is contraindicated in patients with a D. It is approved only for bipolar depression,
history of substance use disorder. not unipolar depression.
Correct: B - It requires a 2-hour post-dose observation period in a certified healthcare
setting.
Rationale:Esketamine must be administered in a certified setting with 2-hour monitoring for
dissociation and blood pressure changes. At-home use is not approved. Substance use
disorder is a caution, not absolute contraindication. It is approved for treatment-resistant
unipolar depression, not bipolar depression.
Q5.
A patient with borderline personality disorder engages in self-harm when feeling
abandoned. Which psychotherapy approach has the strongest evidence for reducing
Page 4
